English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Dec 3, 2025

New UK/EU regulations and AI adoption shape priorities for contract research organizations
+ Pharmaceuticals
Patient Daily | Dec 3, 2025

ENT & Allergy Associates partners with Houston group for first Texas expansion
+ Pharmaceuticals
Patient Daily | Dec 3, 2025

American Lung Association opposes proposed weakening of federal vehicle fuel economy rules
+ Pharmaceuticals
Patient Daily | Dec 2, 2025

American Lung Association calls for widespread flu vaccination after severe 2024–25 season
+ Pharmaceuticals
Patient Daily | Dec 2, 2025

Experts question FDA official's claims linking child deaths to COVID-19 vaccines
+ Pharmaceuticals
Patient Daily | Dec 2, 2025

FDA drug center head Richard Pazdur announces retirement after brief tenure
+ Pharmaceuticals
Patient Daily | Dec 2, 2025

Roche announces promising interim results for new Alzheimer’s antibody trontinemab
+ Pharmaceuticals
Patient Daily | Dec 1, 2025

PhRMA Senior Director on 340B abuse: 'If Congress is serious about lowering drug costs, they must reform 340B'

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes